Drug Price Trends for SM CHILD IBUPROFEN

Average Pharmacy Cost for SM CHILD IBUPROFEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
SM CHILD IBUPROFEN 100 MG/5 ML	70677-0152-01	0.03475	ML	2025-03-19
SM CHILD IBUPROFEN 100 MG/5 ML	70677-0153-01	0.03475	ML	2025-03-19
SM CHILD IBUPROFEN 100 MG/5 ML	70677-0151-01	0.03475	ML	2025-03-19
SM CHILD IBUPROFEN 100 MG/5 ML	70677-0150-01	0.03475	ML	2025-03-19
SM CHILD IBUPROFEN 100 MG/5 ML	70677-0150-02	0.03023	ML	2025-03-19
SM CHILD IBUPROFEN 100 MG/5 ML	70677-0150-01	0.03453	ML	2025-02-19

Global Ibuprofen Market Analysis and Price Projections

Introduction

Ibuprofen, a widely used nonsteroidal anti-inflammatory drug (NSAID), is a staple in the treatment of various chronic and acute conditions, including rheumatoid arthritis, osteoarthritis, headaches, and fever. This article provides a comprehensive market analysis and price projections for ibuprofen, particularly focusing on the segment relevant to SM Child Ibuprofen.

Market Size and Growth

The global ibuprofen market is experiencing steady growth, driven by several key factors. As of 2023, the market size was valued at USD 1.43 billion and is projected to reach USD 1.76 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 2.44% during the forecast period (2024-2032)[1][3].

Drivers of Market Growth

Several factors are driving the growth of the ibuprofen market:

Rising Urbanization and Healthcare Spending

Increasing urbanization and rising healthcare spending are significant drivers. In regions like the Asia-Pacific, where healthcare expenditures are on the rise, the demand for ibuprofen is expected to increase substantially[1].

Public Awareness of Chronic Diseases

Growing public awareness about chronic diseases such as rheumatoid arthritis, osteoarthritis, cardiovascular diseases, and cancer is also boosting the demand for ibuprofen. These conditions require effective pain management and anti-inflammatory treatments, for which ibuprofen is often prescribed[1][3].

Aging Population

The aging population, particularly in countries like India, is another key factor. The elderly are more prone to multiple chronic illnesses, which in turn increases the demand for ibuprofen[1].

Market Segmentation

The global ibuprofen market is segmented based on dosage form, type, end-user, and application.

Application

Ibuprofen is used in various applications, including rheumatoid arthritis and osteoarthritis, cancer, pain/fever/dysmenorrhea, inflammatory diseases, and headaches. Rheumatoid arthritis and osteoarthritis are expected to dominate the revenue share due to ibuprofen's potent analgesic and anti-inflammatory properties[1].

End-Users

The market is segmented into Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), and pharmaceutical and biopharmaceutical companies. Pharmaceutical and biopharmaceutical companies are anticipated to hold the highest market share due to the increasing development of ibuprofen Active Pharmaceutical Ingredients (APIs)[1].

Regional Analysis

The Asia-Pacific region is the largest market shareholder and is expected to expand substantially during the forecast period. This growth is driven by cost-efficient manufacturing in countries like China and India, along with increasing healthcare expenditures in the region[1].

Competitive Landscape

Strategic initiatives by key industry players, such as partnerships, product launches, and acquisitions, are contributing to market growth. For example, IOL Chemicals & Pharmaceuticals invested INR 300 crore in capital expenditures to establish a new plant in western India, which is expected to bolster the country's market share[1].

Price Projections

Given the steady growth rate and increasing demand, the prices of ibuprofen are expected to remain stable or see a slight increase. Here are some key points to consider:

Market Size Projections

The market is projected to grow from USD 1.43 billion in 2023 to USD 1.76 billion by 2032. This growth indicates a stable demand and potentially stable or slightly increasing prices[1].

Cost Factors

The cost of production, particularly in regions like the Asia-Pacific, is relatively low due to efficient manufacturing processes. This could help maintain competitive pricing in the market[1].

Healthcare Spending

Increasing healthcare spending globally is likely to support the market growth without significantly impacting the price volatility of ibuprofen[1].

Use in Pediatric Care

For SM Child Ibuprofen specifically, the market trends in pediatric care are noteworthy. Studies have shown that the combination of paracetamol and ibuprofen is effective in treating fever in children, with ibuprofen increasingly being used due to its efficacy[2][4].

Cost-Effectiveness

In pediatric care, the use of ibuprofen, especially in combination with paracetamol, has been found to be cost-effective. For instance, a study indicated that the combined therapy was the cheapest option for the NHS due to lower healthcare service usage[4].

Key Takeaways

• Market Growth: The global ibuprofen market is expected to grow at a CAGR of 2.44% from 2024 to 2032.
• Drivers: Rising urbanization, public awareness of chronic diseases, and an aging population are key drivers.
• Segmentation: Rheumatoid arthritis and osteoarthritis dominate the application segment, while pharmaceutical and biopharmaceutical companies hold the highest market share among end-users.
• Regional Analysis: The Asia-Pacific region is the largest market shareholder and is expected to expand significantly.
• Price Projections: Prices are expected to remain stable or see a slight increase due to steady market growth and efficient production costs.

FAQs

1. What is the projected market size of the global ibuprofen market by 2032?

   • The global ibuprofen market is estimated to reach USD 1.76 billion by 2032[1].

2. What are the primary drivers of the global ibuprofen market growth?

   • The primary drivers include rising urbanization, increasing public awareness of chronic diseases, and an aging population[1][3].

3. Which region holds the largest market share in the global ibuprofen market?

   • The Asia-Pacific region holds the largest market share and is expected to expand substantially during the forecast period[1].

4. How is ibuprofen used in pediatric care?

   • Ibuprofen is often used in combination with paracetamol to treat fever in children and has been found to be effective and cost-effective[2][4].

5. What are the key segments of the global ibuprofen market?

   • The market is segmented based on dosage form, type, end-user, and application, with rheumatoid arthritis and osteoarthritis dominating the application segment[1].

Sources

1. Straits Research: Global Ibuprofen Market Size, Top Share, CAGR of 2.44%, Report.
2. BMJ: Paracetamol plus ibuprofen for the treatment of fever in children.
3. Verified Market Research: Ibuprofen Market Size, Share, Scope, Trends, Growth & Forecast.
4. NIHR Journals Library: Paracetamol and Ibuprofen for the treatment of fever in children.